| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ALEXION PHARMACEUTIC | 8,599 | 1,640,000 | 15.09% | ||
| 2 | INCYTE | 14,756 | 1,600,000 | 14.72% | ||
| 3 | REGENERON PHARMACEUTICALS | 2,916 | 1,583,000 | 14.56% | ||
| 4 | DEXCOM | 19,046 | 1,560,000 | 14.35% | ||
| 5 | ARATANA THERAPEUTICS INC COM | 218,515 | 1,219,000 | 11.21% | ||
| 6 | ACADIA PHARMACEUTICALS INC COM | 29,801 | 1,062,000 | 9.77% | ||
| 7 | ATHENA HEALTH INC. | 4,900 | 789,000 | 7.26% | ||
| 8 | LILLY ELI & CO | 8,898 | 750,000 | 6.90% | ||
| 9 | AERIE PHARMACEUTICALS INC | 14,962 | 364,000 | 3.35% | ||
| 10 | EDWARDS LIFESCIENCES CORP | 38,322 | 303,000 | 2.79% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-002768, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
